# Bio-export control & dual-use compliance Software platforms and data providers that classify controlled biotechnology and life-science goods, screen counterparties against denied-party and sanctions lists, and trace supply-chain and ownership networks so exporters of dual-use bio-related technology stay inside US, EU and allied export-control regimes. Source: https://en.bioecon.ru/technology/bio-export-control-dual-use-compliance/ Updated: 2026-08-18 ## Overview and value chain Markers: [EC: Dual-use export classification & denied-party screening software | OECD: Bioeconomy policy & governance | Regulator: BIS (US), EU Dual-Use Regulation] Bio-export control and dual-use compliance is a B2B services category that classifies controlled biotechnology and life-science goods under national export-control lists, screens trading counterparties against denied-party and sanctions lists, and traces the ownership and supply-chain networks behind a buyer to catch indirect or forced-labor-linked risk before a shipment leaves the exporter's control. Exiger runs the 1Exiger trade-compliance and third-party risk platform, recently launching 1Exiger.AI, an AI-native operating network trusted by more than 150 Fortune 500 companies and 60+ federal agencies to trace hidden downstream supply-chain entities. Kharon provides export-control and forced-labor compliance data that goes beyond published denied-party lists, helping technology and life-science exporters move from name-based screening to full network visibility of restricted entities' ownership structures. Descartes Systems Group operates the Descartes Visual Compliance denied-party screening platform, adding AI-enabled false-positive reduction in 2025 and onboarding customers such as flavor and fragrance group Givaudan in 2026. MIC Customs Solutions runs export-control and global-trade-management software, certified for SAP S/4HANA Cloud Private Edition in 2026 and building an agentic-AI platform for trade-compliance workflows. World-Check, an LSEG data product, maintains a proprietary structured screening and due-diligence database spanning North America, Asia-Pacific, EMEA and Latin America since 2000. Thomson Reuters' ONESOURCE Global Trade suite covers export/import classification, free-trade-agreement management and duty optimization as part of a broader global-trade-compliance product line. The key directions of bio-export control and dual-use compliance are: 1. **Dual-use export classification:** determining which national export-control list (e.g., the US Commerce Control List, the EU dual-use list) a controlled biotechnology, genetic-engineering tool or life-science instrument falls under, and what license requirement follows. 2. **Denied-party and sanctions screening:** checking every counterparty in a transaction — buyer, freight forwarder, end-user — against government denied-party, sanctions and restricted-entity lists before a shipment proceeds. 3. **Network-based ownership and entity-risk mapping:** tracing beneficial-ownership and supply-chain networks behind a counterparty to catch indirect exposure to a restricted entity that simple name-matching would miss. 4. **End-use and end-user due diligence:** verifying the declared end use and end user of a controlled item to detect diversion risk, particularly for dual-use biotechnology with both civilian and defense-relevant applications. ### Sectoral value chain ``` [Product/technology classification] ──> [License determination] ──> [Counterparty & sanctions screening] │ (Beneficial-ownership network trace) │ [Shipment clearance] <──── [End-use/end-user due diligence] <─── [Restricted-entity risk scoring] ``` ### Value chain levels | Level | Description | Key inputs/outputs | |:---|:---|:---| | **Product/technology classification** | Determining which national export-control list and classification code a controlled biotechnology or life-science item falls under. | **In:** Product/technology specification.
**Out:** Export-control classification code. | | **License determination** | Establishing whether the classified item requires an export license for the destination, end user and end use in question. | **In:** Export-control classification code, destination/end-user data.
**Out:** License requirement determination. | | **Counterparty and sanctions screening** | Checking every counterparty in the transaction against denied-party, sanctions and restricted-entity lists. | **In:** Counterparty identity data.
**Out:** Screening match/no-match result. | | **Restricted-entity risk scoring** | Scoring counterparty and transaction risk based on screening results and known restricted-entity network links. | **In:** Screening results.
**Out:** Risk score. | | **Beneficial-ownership network trace** | Tracing the ownership and corporate-network structure behind a counterparty to detect indirect exposure to a restricted entity. | **In:** Risk score, corporate-registry data.
**Out:** Ownership-network map. | | **End-use/end-user due diligence and shipment clearance** | Verifying the declared end use and end user, then clearing the shipment for export once all checks pass. | **In:** Ownership-network map, end-use declaration.
**Out:** Shipment clearance decision. | Cross-cutting technologies of the sector: - **Denied-party screening:** automated checking of every named counterparty in a transaction against government denied-party, sanctions and restricted-entity lists. - **Export-control classification:** the specific practice of determining which national control list and classification code a dual-use item falls under, and the license requirement that follows. - **Network-based entity-risk mapping:** tracing beneficial-ownership and supply-chain networks behind a counterparty to surface indirect exposure to a restricted entity that name-matching alone would miss. --- ## US The United States hosts the leading trade-compliance data and software providers building on Bureau of Industry and Security requirements, several combining AI-driven network analysis with traditional denied-party screening. ### Exiger's 1Exiger.AI network platform, Kharon's network-visibility data, Thomson Reuters' ONESOURCE Global Trade suite - **Exiger:** runs the 1Exiger trade-compliance and third-party risk platform, recently launching 1Exiger.AI, trusted by more than 150 Fortune 500 companies and 60+ federal agencies to trace hidden downstream supply-chain entities. - **Kharon:** provides export-control and forced-labor compliance data that goes beyond published denied-party lists, helping exporters move from name-based screening to full network visibility of restricted entities' ownership structures. - **Thomson Reuters (ONESOURCE Global Trade):** covers export/import classification, free-trade-agreement management and duty optimization as part of its broader global-trade-compliance product suite. --- ## CN China is covered qualitatively rather than through a live-screened Chinese vendor: candidate Chinese compliance firms searched during this screen returned no confirming 2026 source specific to export-control or dual-use compliance services, and China regulates dual-use exports under its own Export Control Law and control-list framework rather than the US/EU regimes that define most of this category's commercial tooling market. ### No China-headquartered vendor confirmed in this screen - **Search outcome:** two candidate Chinese firms were searched during this screen and neither returned a confirming live 2026 source for this specific service category. - **Structural difference:** China's Export Control Law (2020) and its own control lists operate independently of the US Commerce Control List and EU dual-use list, so a Chinese-market compliance vendor would likely serve a distinct regulatory stack rather than the US/EU-anchored tooling market this article screens. --- ## EU Europe hosts specialist customs and trade-compliance software vendors alongside a major global risk-data provider, serving exporters navigating the EU Dual-Use Regulation across fragmented national licensing authorities. ### MIC Customs Solutions' export-control software, World-Check's global screening database - **MIC Customs Solutions:** headquartered in Austria, runs export-control and global-trade-management software, certified for SAP S/4HANA Cloud Private Edition in 2026 and building an agentic-AI platform for trade-compliance workflows. - **World-Check (LSEG):** headquartered in the UK, maintains a proprietary structured screening and due-diligence database spanning North America, Asia-Pacific, EMEA and Latin America since 2000. --- ## Leading companies and research institutes | Company / Institute | Country | Key products / platforms | Tech features | Status 2026 | |:---|:---|:---|:---|:---| | **Exiger** | 🇺🇸 USA | 1Exiger trade-compliance platform | 1Exiger.AI network operating system | commercial | | **Kharon** | 🇺🇸 USA | Export-control & forced-labor compliance data | Network-visibility beyond denied-party lists | commercial | | **Descartes Systems Group** | 🇨🇦 Canada | Descartes Visual Compliance screening | AI-enabled false-positive reduction | commercial | | **MIC Customs Solutions** | 🇦🇹 Austria | Export-control & global-trade software | SAP S/4HANA-certified, agentic AI | commercial | | **World-Check (LSEG)** | 🇬🇧 UK | Global screening & due-diligence database | Coverage since 2000, 4-region span | commercial | | **Thomson Reuters ONESOURCE** | 🇺🇸 USA | Global Trade classification suite | FTA management, duty optimization | commercial | --- ## Tech stack and innovations The bio-export control and dual-use compliance technology stack is shifting from static denied-party list matching toward AI-driven network analysis that surfaces indirect and beneficial-ownership risk: 1. **AI-native supply-chain network mapping:** - Exiger's 1Exiger.AI has uncovered over 20,000 hidden downstream entities in customer supply chains, reducing screening signal noise materially versus name-based matching alone. 2. **Network-visibility export-control data:** - Kharon's data model moves beyond BIS Entity List screening and published denied-party lists to map ownership structures and end-use risk across a counterparty's full network. 3. **AI-enabled denied-party screening:** - Descartes' Visual Compliance platform added AI-enabled false-positive reduction in 2025, cutting the manual review burden for exporters like Givaudan. --- ## Value chains and production pipelines ### Industrial pipeline for a controlled bio-technology export transaction ``` ┌───────────────────────────┐ ┌───────────────────────────┐ │ 1. Product/technology │ ───> │ 2. License │ │ classification │ │ determination │ └───────────────────────────┘ └───────────────────────────┘ │ ▼ ┌───────────────────────────┐ ┌───────────────────────────┐ │ 4. Restricted-entity │ <─── │ 3. Counterparty & │ │ risk scoring │ │ sanctions screening │ └───────────────────────────┘ └───────────────────────────┘ │ ▼ ┌───────────────────────────┐ ┌───────────────────────────┐ │ 5. Beneficial-ownership │ ───> │ 6. End-use/end-user │ │ network trace │ │ due diligence & clearance │ └───────────────────────────┘ └───────────────────────────┘ ``` #### Stage 1: Product/technology classification The controlled biotechnology or life-science item is classified against the applicable national export-control list. #### Stage 2: License determination Whether the classified item requires an export license for the destination, end user and end use in question is established. #### Stage 3: Counterparty and sanctions screening Every counterparty in the transaction is checked against denied-party, sanctions and restricted-entity lists. #### Stage 4: Restricted-entity risk scoring Counterparty and transaction risk is scored based on screening results and known restricted-entity network links. #### Stage 5: Beneficial-ownership network trace The ownership and corporate-network structure behind a counterparty is traced to detect indirect exposure to a restricted entity. #### Stage 6: End-use/end-user due diligence and shipment clearance The declared end use and end user are verified, and the shipment is cleared for export once all checks pass.